Planet Fitness (NYSE:PLNT) reported strong top-line growth for the first quarter of 2026, though management struck a cautious tone by lowering full-year expectations and halting a planned pricing adjustment.
Edgewell Personal Care Company (NYSE:EPC) reported modest top-line growth for the second quarter of fiscal 2026, as the company continues to navigate a shifting retail environment through a comprehensive multi-year restructuring program.
Former NFL Quarterback Tom Brady & eMed CEO Linda Yaccarino discuss investment in health startup eMed, soaring GLP-1 weight-loss drug costs, and how to evaluate business opportunities as a well-known former athlete. They speak with Katie Greifeld and Romaine Bostick at the Milken Institute Global Conference in Beverly Hills, California.
Lancôme Global Brand President Vania Lacascade discusses why longevity will be the next shift for the beauty industry, and how brands are tapping into the wellness boom. She talks with Romaine Bostick on "The Close."
OneSpaWorld Holdings (NASDAQ:OSW) unveiled its financial results for the first quarter ended March 31, 2026, highlighting sustained momentum in the global cruise and resort wellness sectors.
FDA Commissioner Dr. Marty Makary discusses President Trump's Executive Order aimed at faster research and access to psychedelics, citing promising research and calling this an 'historic moment.' He talks with Romaine Bostick and Katie Greifeld on "The Close."
23andMe Research Institute Founder & CEO Anne Wojcicki discusses the company's strategic shift after reacquisition, being early into the DTC movement, and the decision to not actively work with AI firms for the time being. She talks with Katie Greifeld and Isabelle Lee on "The Close."
Khloé Kardashian's Khloud is expanding into protein chips. As America's protein obsession grows, the celebrity-founded snack brand is betting big on high-protein snacks to capture the booming market. Khloud CEO Jeff Rubenstein joined Bloomberg Open Interest breaks down the strategy behind the launch, the future of protein snacks, and how the brand plans to compete in the crowded health food space.
Novo Nordisk Executive Vice President for US Operations Jamey Millar discusses the US approval of competitor Eli Lilly's obesity pill, the expansion of the GLP-1 category, and the rollout of a new subscription model. He talks with Katie Greifeld for "The Close."
Tilray Brands (NASDAQ:TLRY) reported record financial results for its third quarter of fiscal 2026, ended February 28, 2026, on Wednesday, April 1.
